Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 4:50 PM View:  | Karnani Vikram President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 12-Nov-24 | Grant | 105,972 | -- | -- | 100% 0 to 105.97K | |
| 17-Sep-24 4:32 PM View: | Smith Thomas B EVP and Chief Medical Officer | Collegium Pharmaceutical, Inc (COLL) | 13-Sep-24 | Private Sale | 9,593 | $36.62 | $351,320.00 | (15%) 63.41K to 53.82K | |
| 06-Sep-24 5:52 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 06-Sep-24 | Sale | 977 | $37.46 | $36,594.10 | (< 1%) 120.16K to 119.18K | |
| 06-Sep-24 5:52 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 05-Sep-24 | Private Sale | 19,248 | $38.30 | $737,198.00 | (14%) 139.41K to 120.16K | |
| 05-Jun-24 4:06 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 03-Jun-24 | Private Sale (Planned) | 25,000 | $32.57 | $814,180.00 | (15%) 164.41K to 139.41K | |
| 29-May-24 4:29 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 28-May-24 | Private Sale (Planned) | 19,710 | $34.21 | $674,368.00 | (13%) 150.56K to 130.84K | |
| 28-May-24 4:22 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 24-May-24 | Sale | 33,016 | $33.98 | $1,121,970.00 | (24%) 138.92K to 105.9K | |
| 28-May-24 4:22 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 24-May-24 | Option Sale | 23,791 | $33.98 | $808,482.00 | (15%) 162.71K to 138.92K | |
| 28-May-24 4:22 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 24-May-24 | Option Exercise | 23,791 | $24.03 | $571,698.00 | 17% 138.92K to 162.71K | |
| 28-May-24 4:22 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 23-May-24 | Option Sale | 51,209 | $33.82 | $1,732,090.00 | (27%) 190.13K to 138.92K | |
| 28-May-24 4:22 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 23-May-24 | Option Exercise | 51,209 | $24.03 | $1,230,550.00 | 37% 138.92K to 190.13K | |
| 16-May-24 7:23 PM View: | Santini Gino Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 11% 67.96K to 75.66K | |
| 16-May-24 7:20 PM View: | Bohlin Garen G Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 17% 44.77K to 52.47K | |
| 16-May-24 7:21 PM View: | Heffernan Michael Thomas Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 20% 37.81K to 45.51K | |
| 16-May-24 7:23 PM View: | McFarlane Neil F. Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 18% 41.67K to 49.37K | |
| 16-May-24 7:23 PM View: | Melincoff Gwen A Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 17% 44.77K to 52.47K | |
| 16-May-24 7:22 PM View: | Fallon John A. Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 16% 47.15K to 54.84K | |
| 16-May-24 7:22 PM View: | Freund John Gordon Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 9% 88.19K to 95.88K | |
| 16-May-24 7:22 PM View: | Balice-Gordon Rita J. Director | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 20% 38.8K to 46.49K | |
| 16-May-24 7:20 PM View: | Bohlin Garen G Director | Collegium Pharmaceutical, Inc (COLL) | 14-May-24 | Option Exercise | 28,985 | $5.73 | $166,084.00 | 65% 44.77K to 73.76K | |
| 16-May-24 7:20 PM View: | Bohlin Garen G Director | Collegium Pharmaceutical, Inc (COLL) | 14-May-24 | Option Sale | 28,985 | $32.30 | $936,311.00 | (39%) 73.76K to 44.77K | |
| 04-Mar-24 4:26 PM View: | Smith Thomas B EVP and Chief Medical Officer | Collegium Pharmaceutical, Inc (COLL) | 29-Feb-24 | Private Sale | 995 | $36.76 | $36,580.20 | (2%) 64.4K to 63.41K | |
| 28-Feb-24 10:00 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 26-Feb-24 | Private Sale (Planned) | 10,000 | $36.43 | $364,270.00 | (7%) 148.92K to 138.92K | |
| 14-Feb-24 4:15 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 71,456 | -- | -- | 68% 105.42K to 176.88K | |
| 14-Feb-24 4:13 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 128,867 | $33.70 | $4,342,820.00 | (22%) 573.73K to 444.87K | |
| 14-Feb-24 4:14 PM View: | Smith Thomas B EVP and Chief Medical Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 3,199 | $33.70 | $107,806.00 | (5%) 67.6K to 64.4K | |
| 14-Feb-24 4:14 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 76,647 | -- | -- | 64% 119.52K to 196.16K | |
| 14-Feb-24 4:14 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 67,286 | -- | -- | 60% 111.32K to 178.61K | |
| 14-Feb-24 4:15 PM View: | Tupper Colleen EVP & Chief Financial Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 26,321 | $33.70 | $887,018.00 | (15%) 176.88K to 150.56K | |
| 14-Feb-24 4:14 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 31,756 | $33.70 | $1,070,180.00 | (16%) 196.16K to 164.41K | |
| 14-Feb-24 4:14 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Payment of Exercise | 29,690 | $33.70 | $1,000,550.00 | (17%) 178.61K to 148.92K | |
| 14-Feb-24 4:13 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 298,734 | -- | -- | 109% 275.0K to 573.73K | |
| 14-Feb-24 4:14 PM View: | Smith Thomas B EVP and Chief Medical Officer | Collegium Pharmaceutical, Inc (COLL) | 12-Feb-24 | Grant | 35,423 | -- | -- | 110% 32.18K to 67.6K | |
| 18-Jan-24 4:19 PM View: | Dreyer Scott EVP & Chief Commercial Officer | Collegium Pharmaceutical, Inc (COLL) | 16-Jan-24 | Private Sale (Planned) | 23,560 | $32.28 | $760,519.00 | (17%) 134.88K to 111.32K | |
| 22-Dec-23 4:36 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-23 | Option Exercise | 4,357 | $21.34 | $92,978.40 | 2% 275.0K to 279.36K | |
| 22-Dec-23 4:36 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 21-Dec-23 | Planned Option Sale | 4,357 | $30.38 | $132,377.00 | (2%) 279.36K to 275.0K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-23 | Option Exercise | 26,454 | $21.34 | $564,528.00 | 10% 275.0K to 301.45K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 20-Dec-23 | Planned Option Sale | 26,454 | $30.40 | $804,210.00 | (9%) 301.45K to 275.0K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-23 | Planned Option Sale | 14,516 | $30.03 | $435,942.00 | (5%) 289.52K to 275.0K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 19-Dec-23 | Option Exercise | 14,516 | $21.34 | $309,771.00 | 5% 275.0K to 289.52K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 18-Dec-23 | Option Exercise | 27,798 | $21.34 | $593,209.00 | 10% 275.0K to 302.8K | |
| 20-Dec-23 5:51 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 18-Dec-23 | Planned Option Sale | 27,798 | $30.04 | $834,935.00 | (9%) 302.8K to 275.0K | |
| 29-Nov-23 4:32 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 27-Nov-23 | Planned Option Sale | 25,600 | $25.78 | $660,014.00 | (18%) 145.12K to 119.52K | |
| 29-Nov-23 4:32 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 27-Nov-23 | Option Exercise | 25,600 | $15.90 | $407,040.00 | 21% 119.52K to 145.12K | |
| 28-Jun-23 4:08 PM View: | Kuhlmann Shirley R. EVP and General Counsel | Collegium Pharmaceutical, Inc (COLL) | 26-Jun-23 | Private Sale (Planned) | 17,984 | $21.72 | $390,633.00 | (13%) 137.5K to 119.52K | |
| 02-Jun-23 7:08 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 02-Jun-23 | Sale (Planned) | 31,272 | $21.60 | $675,424.00 | (10%) 306.27K to 275.0K | |
| 02-Jun-23 7:08 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 01-Jun-23 | Private Sale (Planned) | 31,272 | $22.09 | $690,758.00 | (9%) 337.54K to 306.27K | |
| 01-Jun-23 4:15 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 31-May-23 | Sale (Planned) | 31,272 | $21.87 | $683,797.00 | (8%) 368.82K to 337.54K | |
| 01-Jun-23 4:15 PM View: | Ciaffoni Joseph President and CEO Director | Collegium Pharmaceutical, Inc (COLL) | 30-May-23 | Private Sale (Planned) | 31,271 | $21.90 | $684,907.00 | (8%) 400.09K to 368.82K | |
| 19-May-23 4:39 PM View: | Fallon John A. Director | Collegium Pharmaceutical, Inc (COLL) | 18-May-23 | Grant | 9,792 | -- | -- | 26% 37.36K to 47.15K |
